A report from CB Insights' State of Venture for the first quarter of 2024 showed that deal-making dropped to a 7-year low in Q1, and was the eighth straight quarter of a drop in equity deal volume.
Cellectis Reports Financial Results for First Quarter 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, May 02, 2024 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the.